http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106176707-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106176707-B |
| titleOfInvention | Application of terpenoid camphene composite ester |
| abstract | An application of terpenoid camphene composite ester relates to terpenoid camphene composite ester. The terpenoid camphene composite ester is a compound Tschmgine with a molecular formula of C 17 H 22 O 3 . The terpene camphene composite ester can be applied to the preparation of medicaments for preventing or treating diabetes, fatty liver, liver cirrhosis, obesity, hyperglycemia, hypertriglyceridemia, hypercholesterolemia, cardiovascular diseases, atherosclerosis, liver injury, inflammation, kidney diseases and the like; can be used for preparing health products for preventing or treating diabetes, fatty liver, liver cirrhosis, obesity, hyperglycemia, hypertriglyceridemia, hypercholesterolemia, cardiovascular diseases, atherosclerosis, liver injury, inflammation, kidney diseases, etc. The camphene composite ester can be used as an active ingredient to be mixed with other medicines, and then the active ingredient is mixed with pharmaceutically acceptable excipient/or administration carrier to prepare a pharmaceutical composition according to the requirements of conventional pharmaceutical method and process, wherein the pharmaceutical composition can be prepared by oral administrationA medicine taking preparation or an injection preparation. |
| priorityDate | 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.